@EcmmCandidaIV
Joined April 2025
  • Tweets12
  • Following15
  • Followers25
3Media
Excited to share our new publication: Clinical Characteristics, Management and Outcomes of Non-ICU Candidemia – a subanalysis of the ECMM Candida III multinational European cohort study. 😊 academic.oup.com/ofid/articl… @martinhoenigl @SarahSedik @jprattes @CornelyOliver

Clinical Characteristics, Management and Outcomes of Nonintensive Care Unit Candidemia: Subanalysis...

A subanalysis of 396 candidemia cases diagnosed outside the intensive care unit from the pan-European multicenter ECMM Candida III study showed higher surv

academic.oup.com
3
6
301
Clinical characteristics, management and outcomes of non-ICU candidemia: Sub-analysis of the ECMM Candida III multinational European observational cohort study @eurconfmedmycol @Stella_A_I @SarahSedik @EcmmCandidaIV academic.oup.com/ofid/articl…

Clinical Characteristics, Management and Outcomes of Nonintensive Care Unit Candidemia: Subanalysis...

A subanalysis of 396 candidemia cases diagnosed outside the intensive care unit from the pan-European multicenter ECMM Candida III study showed higher surv

academic.oup.com
10
12
692
Update on Candida IV study at #TIMM2025 Still open for registration 🔬🧫🧪 Join now!
2
2
154
Preliminary results of the Candida IV study at #ISHAM2025 Study is still open to join 🔬🥼👩‍🔬
1
3
177
🧫 Persistent candidemia: lessons from a European cohort In 258 patients from 18 countries, 20% had ≥5 days of (+) cultures → higher mortality (50% vs 32%). Low EQUAL #Candida Scores predicted persistence 💡 Adherence saves lives 🔗 journalofinfection.com/artic…
3
19
32
1,769
⏰Only 70 days left to join the ECMM #CandidaIV study! 🌎 A global, multicenter study on non-albicans Candida infections 🔬 Focus: Resistance, tolerance & clinical outcomes in #candidemia 📅 Enrollment open until September 30, 2025 📥 Register now and be part of it!
4
4
367
Proud to present the progress of @EcmmCandidaIV study at #ISHAM2025 @ISHAM_Mycology @eurconfmedmycol Still open for participation!
1
7
1
36
1,229
Exciting news! The ECMM Candida IV study is now featured on the ECMM website! Find all the details here: ecmm.info/working-groups/221… ⁦@martinhoenigl⁩ ⁦@Stella_A_I⁩ ⁦@SarahSedik⁩ ecmm.info/working-groups/221…

Antifungal tolerance, resistance and clinical outcomes on candidemia caused by non-albicans...

ECMM Candida IV Antifungal tolerance, resistance and clinical outcomes on candidemia caused by non-albicans Candida  Observation periods/Timeline Observation period: April 1, 2024 – September 30,...

ecmm.info
6
9
399
🎉 Exciting news from #ESCMIDGlobal2025! Proud to present our ECMM Candida IV study Poster at #ESCMID2025! Great discussions and inspring feedback - thanks to everyone who stopped by! #Candida #ClinicalResearch #ESMID #PosterPresentation #Oraltalk
5
10
527
ECMM Candida IV retweeted
Sarah Sedik@SarahSedik14 Apr 2025
Join our Global ECMM Candida IV Study 🍄 @eurconfmedmycol @EcmmCandidaIV @martinhoenigl @Stella_A_I #ESCMIDGlobal2025
3
6
15
821
ECMM Candida IV Study is still open for participation Global study on non-albicans candidemia Requirements: 🔬Clinical data + isolates (no limit per site) 📅Apr 2024-Sep 2025 📦Ship isolates in one batch at study end 💰Case-based reimbursement available @eurconfmedmycol
2
6
9
497
Load more